HMOX1 and mature T-cell and NK-cell non-Hodgkin lymphoma: Overall, our inspiring findings demonstrated that targeting PTGDS promoted the ferroptosis in PTCL through regulating HMOX1-mediated iron metabolism, and provided novel prognostic biomarkers, molecular targets and combination regimen for PTCL treatment.